...
首页> 外文期刊>Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy >In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018-19 season: Comparison with the 2010-11 to 2017-18 seasons
【24h】

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018-19 season: Comparison with the 2010-11 to 2017-18 seasons

机译:在2018-19赛季的四个神经氨酸酶抑制剂的体外神经氨酰胺酶抑制浓度(IC50):与2010-11至2017-18赛季比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To assess the extent of susceptibility to the four most commonly used neuraminidase inhibitors (NAIs) of the epidemic viruses in the 2018-19 Japanese influenza season, we measured the 50% inhibitory concentration (IC50) of four NAIs, oseltamivir, zanamivir, peramivir, and laninamivir, for influenza virus isolates from patients and compared them with the results from the 2010-11 to 2017-18 seasons.
机译:为了评估2018-19年日本流感季节流行病毒对四种最常用的神经氨酸酶抑制剂(NAI)的易感性程度,我们测量了四种NAI、奥司他韦、扎那米韦、佩拉米韦和拉那米韦的50%抑制浓度(IC50),并将其与2010-11年至2017-18年期间的结果进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号